Atherosclerosis in HIV patients: A new face for an old disease?

AIDS Reviews

Volumn 8, Issue 4, 2006, Pages 204-209

  Maggi, Paolo ^a   Maserati, Renato ^a   Antonelli, Gianfranco ^a  

^a POLICLINICO   (Italy)

Author keywords

Antiretroviral therapy; Arteritis; Atherosclerosis; HIV

Indexed keywords

ANTIRETROVIRUS AGENT; CD31 ANTIGEN; COLONY STIMULATING FACTOR 1; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INDINAVIR; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; INTERCELLULAR ADHESION MOLECULE 3; INTERLEUKIN 6; LYMPHOTOXIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTERITIS; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CYTOTOXICITY; DISEASE COURSE; DISEASE SEVERITY; DNA DAMAGE; DRUG EFFICACY; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM INJURY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; HYPOTHESIS; IMMUNE DEFICIENCY; INFLAMMATION; INFLAMMATORY INFILTRATE; INSULIN RESISTANCE; NONHUMAN; REVIEW; RISK FACTOR;

ANIMALS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ATHEROSCLEROSIS; HIV INFECTIONS; HUMANS;

EID: 33846464991     PISSN: 11396121     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Badr K, Wainwright C. Inflammation in the cardiovascular system: here, there and everywhere. Current Op Pharmacol 2004;4:107-9.
2. Rohde L, Lee R. Pathophysiology of atherosclerotic plaque development and rupture: an overview. Semin Vascular Med 2003;3:347-54.
3. Davies M, Gordon J, Pigott R, Woolf F, Katz D, Kyriakopulos A. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 1993;171:223-9.
4. Libby P, Ridker P, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43.
5. Rohde L, Hennekens C, Ridker P. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am J Car-diol 1999;84:1018-22.
6. Blankemberg S, Rupprecht H, Bickel C, et al. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 2001;104:1336-42.
7. Ridker P, Burning J, Rifai N. Soluble P-selectin and the risk of future cardiovascular events. Circulation 2001;103:491-5.
8. Davies M, Gordon J, Gearing A, et al. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM and E-selectin in human atherosclerosis. J Pathol 1993;171:223-9.
9. Frijns C, Kappelle L. Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke 2002;33:2115-22.
10. Ridker P, Hennekens C, Roitman-Johnson B, Stampfer M, Allen J. Plasma concentration of soluble ICAM-1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998;351:88-92.
11. Kuijper P, Gallardo Tores H, Lammers J, et al. Platelet-associated fibrinogen and ICAM-2 induce firm adhesion of neutrophils under flow conditions. Thromb Haemost 1998;80:443-8.
12. Diacovo T, de Fougerolles A, Bainton D, Springer T. A functional integrin ligand on the surface of platelets: ICAM-2, J Clin Invest 1994;94:1243-51.
13. Freedman J. CD40 ligand - assessing risk instead of damage? N Engl J Med 2003;348:1163-5.
14. Inwald D, McDowell A, Peters M, Callard R, Klein N. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 2003;92:1041-8.
15. Cerletti C, Evangelista V, de Gaetano G. P-selectin-beta 2-integrin cross-talk: a molecular mechanism for polymorphonuclear leukocyte recruitment at the site of vascular damage, Thromb Haemost 1999;82:787-93.
16. Davì G, Romano M, Mezzetti A, et al. Increased levels of soluble P-Selectin in hypercholesterolemic patients. Circulation 1998;97: 953-7.
17. Ridker P, Hennekens C, Buring J, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.
18. Hwang P, Ballantyne C, Sharrett A, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 1997;96:4219-25.
19. Mulvihill N, Foley J, Murphy R, et al. Evidence of prolonged inflammation in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol 2000;36:423-6.
20. Lip G, Blann A, Zarifis J, et al. Soluble adhesion molecules P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report. J Hypertens 1995;13:1674-8.
21. Blann A, Dobrotova M, Kubisz P, et al. Von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis. Thromb Haemost 1995;74:626-30.
22. Ikeda H, Takajo Y, Ichiki K, et al. Increased soluble form of P-selectin in patients with unstable angina. Circulation 1995;92: 1693-6.
23. Sakurai S, Inoue A, Koh C, et al. Soluble form of selectins in blood of patients with acute myocardial infarction and coronary intervention. Vasc Med 1997;2:163-8.
24. Shimomura H, Ogawa H, Arai H, et al. Serial changes in plasma levels of soluble P-selectin in patients with acute myocardial infarction. Am J Cardiol 1998;81:397-400.
25. Krishnaswamy G, Smith J, Mukkamala R, Hall K, Joyner W, Chi D. Multifunctional cytokine expression by human coronary endothelium and regulation by monokines and glucocorticoids. Microvasc Res 1998;55:189-200.
26. Horbein G, Koshav S, Collin M, Montaner L, Gordon S. HIV induces TNF and IL-1 gene expression in primary human macrophages independent of productive infection. Clin Exp Immunol 1994;95:442-9.
27. Lifson J, Reyes G, McGrath M, Stein B, Engleman E. AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. Science 1986;232:1123-7.
28. Stefano G, Salzet M, Bilfinger T. Long-term exposure of human blood vessels to HIV gp120 morphine and anandamide increases endothelial adhesion of monocytes: uncoupling of nitric oxide release. J Cardiovasc Pharmacol 1998;31:862-8.
29. Ren Z, Yao Q, Chen C. HIV-1 envelope gp120 increases ICAM-1 expression by human endothelial cells. Lab Invest 2002;82:245-55.
30. Lafeuillade A, Alessi M, Poizot-Martin I, et al. Endothelial cell dysfunction in HIV infection. J Acquir Immune Defic Syndr 1992;5:127-31.
31. Puppo F, Brenci S, Scudeletti M, Lanza L, Bosco O, Indiveri F. Elevated serum levels of circulating ICAM-1 in HIV infection. AIDS 1993;7:593-4.
32. Sipsas N, Sfikakis PP, Sfikakis P, Choremi H, Kordossis T. Serum concentrations of soluble ICAM-1 and progress towards disease in patients infected with HIV. J Infect 1994;29:271-82.
33. Zietz C, Hotz B, Sturzl M, Rauch E, Penning R, Lohrs U. Aortic endothelium in HIV-1 infection: chronic injury, activation and increased leukocyte adherence. Am J Pathol 1996;149:1887-98.
34. Galea P, Vermot-Desroches C, Le Contel C, Wijdenes J, Chermann J. Circulating cell adhesion molecules in HIV-1 infected patients as indicator markers for AIDS progression. Res Immunol 1997;148:109-17.
35. Mastroianni C, Lichtner M, Mengoni F, et al. Changes in circulating levels of soluble cell adhesion molecules following highly active antiretroviral treatment of HIV-1-infected patients. Clin Immunol 2000;95:212-7.
36. Wolf K, Tsakiris D, Weber R, Erb P, Battegay M. Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with HIV-1. J Infect Dis 2002;185:456-62.
37. De Gaetano Donati K, Rabagliati R, Tumbarello M, et al. Increased soluble markers of endothelial dysfunction in HIV-positive patients under HAART. AIDS 2003;17:765-8.
38. Zong D, Lu X, Conklin B, et al. HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells. Arterioscler Thromb Vasc Biol 2002;22:1560-6.
39. Shankar S, Dube M, Gorski J, et al. Indinavir impairs endothelial function in healthy HIV-negative men. Am Heart J 2005;15:933.
40. Jiang B, Hebert V, Zavecz J, Dugas T. Antiretrovirals induce direct endothelial dysfunction in vivo. J Acquir Immune Defic Syndr 2006;42:391-5.
41. De Gaetano Donati K, Rabagliati R, Iacoviello L, et al. HIV infection, HAART, and endothelial adhesion molecules: current perspectives. Lancet Infect Dis 2004;4:213-22.
42. Regina G, Impedovo G, Angiletta D, et al. Surgical experience with carotid stenosis in young HIV-1 positive patients under antiretroviral therapy: an emerging problem? Eur J Vasc Endovasc Surg 2005;29:167.
43. Maggi P, Perilli F, Lillo A, et al. An ultrasound-based comparative study on carotid plaques in HIV-positive patients vs. atherosclerotic and arteritis patients: atherosclerotic or inflammatory lesions? Coronary Artery Disease [in press].